Your browser doesn't support javascript.
loading
Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.
Thomas, Claire E; Georgeson, Peter; Qu, Conghui; Steinfelder, Robert S; Buchanan, Daniel D; Song, Mingyang; Harrison, Tabitha A; Um, Caroline Y; Hullar, Meredith A; Jenkins, Mark A; Van Guelpen, Bethany; Lynch, Brigid M; Melaku, Yohannes Adama; Huyghe, Jeroen R; Aglago, Elom K; Berndt, Sonja I; Boardman, Lisa A; Campbell, Peter T; Cao, Yin; Chan, Andrew T; Drew, David A; Figueiredo, Jane C; French, Amy J; Giannakis, Marios; Goode, Ellen L; Gruber, Stephen B; Gsur, Andrea; Gunter, Marc J; Hoffmeister, Michael; Hsu, Li; Huang, Wen-Yi; Moreno, Victor; Murphy, Neil; Newcomb, Polly A; Newton, Christina C; Nowak, Jonathan A; Obón-Santacana, Mireia; Ogino, Shuji; Sun, Wei; Toland, Amanda E; Trinh, Quang M; Ugai, Tomotaka; Zaidi, Syed H; Peters, Ulrike; Phipps, Amanda I.
Afiliação
  • Thomas CE; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Georgeson P; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.
  • Qu C; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Australia.
  • Steinfelder RS; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Buchanan DD; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Song M; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.
  • Harrison TA; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Australia.
  • Um CY; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Hullar MA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Jenkins MA; Clinical and Translational Epidemiology Unit and Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Van Guelpen B; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Lynch BM; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Melaku YA; Department of Population Science, American Cancer Society, Atlanta, Georgia.
  • Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Aglago EK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • Berndt SI; Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
  • Boardman LA; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Campbell PT; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • Cao Y; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Chan AT; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Drew DA; FHMRI Sleep, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Figueiredo JC; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • French AJ; Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, UK.
  • Giannakis M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Goode EL; Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Gruber SB; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
  • Gsur A; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
  • Gunter MJ; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri.
  • Hoffmeister M; Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Hsu L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Huang WY; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Moreno V; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Murphy N; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Newcomb PA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Newton CC; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Nowak JA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Obón-Santacana M; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Ogino S; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Sun W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Toland AE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Trinh QM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ugai T; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Zaidi SH; Department of Medical Oncology and Therapeutics Research and Center for Precision Medicine, City of Hope National Medical Center, Duarte, California.
  • Peters U; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
  • Phipps AI; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Cancer Epidemiol Biomarkers Prev ; 33(4): 534-546, 2024 Apr 03.
Article em En | MEDLINE | ID: mdl-38252034
ABSTRACT

BACKGROUND:

The genotoxin colibactin causes a tumor single-base substitution (SBS) mutational signature, SBS88. It is unknown whether epidemiologic factors' association with colorectal cancer risk and survival differs by SBS88.

METHODS:

Within the Genetic Epidemiology of Colorectal Cancer Consortium and Colon Cancer Family Registry, we measured SBS88 in 4,308 microsatellite stable/microsatellite instability low tumors. Associations of epidemiologic factors with colorectal cancer risk by SBS88 were assessed using multinomial regression (N = 4,308 cases, 14,192 controls; cohort-only cases N = 1,911), and with colorectal cancer-specific survival using Cox proportional hazards regression (N = 3,465 cases).

RESULTS:

392 (9%) tumors were SBS88 positive. Among all cases, the highest quartile of fruit intake was associated with lower risk of SBS88-positive colorectal cancer than SBS88-negative colorectal cancer [odds ratio (OR) = 0.53, 95% confidence interval (CI) 0.37-0.76; OR = 0.75, 95% CI 0.66-0.85, respectively, Pheterogeneity = 0.047]. Among cohort studies, associations of body mass index (BMI), alcohol, and fruit intake with colorectal cancer risk differed by SBS88. BMI ≥30 kg/m2 was associated with worse colorectal cancer-specific survival among those SBS88-positive [hazard ratio (HR) = 3.40, 95% CI 1.47-7.84], but not among those SBS88-negative (HR = 0.97, 95% CI 0.78-1.21, Pheterogeneity = 0.066).

CONCLUSIONS:

Most epidemiologic factors did not differ by SBS88 for colorectal cancer risk or survival. Higher BMI may be associated with worse colorectal cancer-specific survival among those SBS88-positive; however, validation is needed in samples with whole-genome or whole-exome sequencing available. IMPACT This study highlights the importance of identification of tumor phenotypes related to colorectal cancer and understanding potential heterogeneity for risk and survival.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias Colorretais / Instabilidade de Microssatélites / Policetídeos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias Colorretais / Instabilidade de Microssatélites / Policetídeos Idioma: En Ano de publicação: 2024 Tipo de documento: Article